Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Quantitative ultrasound evaluation of tumor cell death response in locally advanced breast cancer patients receiving chemotherapy.

Sadeghi-Naini A, Papanicolau N, Falou O, Zubovits J, Dent R, Verma S, Trudeau M, Boileau JF, Spayne J, Iradji S, Sofroni E, Lee J, Lemon-Wong S, Yaffe M, Kolios MC, Czarnota GJ.

Clin Cancer Res. 2013 Apr 15;19(8):2163-74. doi: 10.1158/1078-0432.CCR-12-2965. Epub 2013 Feb 20.

2.

Early detection of chemotherapy-refractory patients by monitoring textural alterations in diffuse optical spectroscopic images.

Sadeghi-Naini A, Vorauer E, Chin L, Falou O, Tran WT, Wright FC, Gandhi S, Yaffe MJ, Czarnota GJ.

Med Phys. 2015 Nov;42(11):6130-46. doi: 10.1118/1.4931603.

PMID:
26520706
3.

Non-invasive evaluation of breast cancer response to chemotherapy using quantitative ultrasonic backscatter parameters.

Sannachi L, Tadayyon H, Sadeghi-Naini A, Tran W, Gandhi S, Wright F, Oelze M, Czarnota G.

Med Image Anal. 2015 Feb;20(1):224-36. doi: 10.1016/j.media.2014.11.009. Epub 2014 Nov 25.

PMID:
25534283
4.

Low-frequency quantitative ultrasound imaging of cell death in vivo.

Sadeghi-Naini A, Papanicolau N, Falou O, Tadayyon H, Lee J, Zubovits J, Sadeghian A, Karshafian R, Al-Mahrouki A, Giles A, Kolios MC, Czarnota GJ.

Med Phys. 2013 Aug;40(8):082901. doi: 10.1118/1.4812683.

PMID:
23927356
5.

Quantitative ultrasound spectral parametric maps: early surrogates of cancer treatment response.

Sadeghi-Naini A, Falou O, Czarnota GJ.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:2672-5. doi: 10.1109/EMBC.2012.6346514.

PMID:
23366475
6.

Computer Aided Theragnosis Using Quantitative Ultrasound Spectroscopy and Maximum Mean Discrepancy in Locally Advanced Breast Cancer.

Gangeh MJ, Tadayyon H, Sannachi L, Sadeghi-Naini A, Tran WT, Czarnota GJ.

IEEE Trans Med Imaging. 2016 Mar;35(3):778-90. doi: 10.1109/TMI.2015.2495246. Epub 2015 Oct 27.

PMID:
26529750
7.

Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture.

Sadeghi-Naini A, Sannachi L, Pritchard K, Trudeau M, Gandhi S, Wright FC, Zubovits J, Yaffe MJ, Kolios MC, Czarnota GJ.

Oncotarget. 2014 Jun 15;5(11):3497-511.

8.

Breast magnetic resonance imaging for monitoring response to therapy.

Ojeda-Fournier H, de Guzman J, Hylton N.

Magn Reson Imaging Clin N Am. 2013 Aug;21(3):533-46. doi: 10.1016/j.mric.2013.04.005. Review.

PMID:
23928243
9.

Quantitative ultrasound characterization of locally advanced breast cancer by estimation of its scatterer properties.

Tadayyon H, Sadeghi-Naini A, Wirtzfeld L, Wright FC, Czarnota G.

Med Phys. 2014 Jan;41(1):012903. doi: 10.1118/1.4852875.

PMID:
24387530
10.

Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach.

Tadayyon H, Sannachi L, Gangeh M, Sadeghi-Naini A, Tran W, Trudeau ME, Pritchard K, Ghandi S, Verma S, Czarnota GJ.

Oncotarget. 2016 Jul 19;7(29):45094-45111. doi: 10.18632/oncotarget.8862. Erratum in: Oncotarget. 2017 May 23;8(21):35481.

11.

Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy.

El Kaffas A, Sadeghi-Naini A, Falou O, Tran WT, Zhou S, Hashim A, Fernandes J, Giles A, Czarnota GJ.

Med Phys. 2015 Aug;42(8):4965-73. doi: 10.1118/1.4926554.

PMID:
26233222
13.

Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical spectroscopy.

Tran WT, Childs C, Chin L, Slodkowska E, Sannachi L, Tadayyon H, Watkins E, Wong SL, Curpen B, El Kaffas A, Al-Mahrouki A, Sadeghi-Naini A, Czarnota GJ.

Oncotarget. 2016 Apr 12;7(15):19762-80. doi: 10.18632/oncotarget.7844.

14.

[Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients].

Sun B, Song ST, Wu SK, Jiang ZF, Wang T, Zhang SH, Zhao YB, Yu CZ, Li XB, Yang T, Li GJ.

Zhonghua Zhong Liu Za Zhi. 2009 Oct;31(10):783-5. Chinese.

PMID:
20021835
15.

[O-Twist Marker for marking breast cancer under neoadjuvant chemotherapy--first results].

Viehweg P, Fabel K, Petzold A, Friedrich K, Laniado M.

Rofo. 2007 Oct;179(10):1055-60. Epub 2007 Jun 26. German.

PMID:
17594630
16.

Response rate to neoadjuvant chemotherapy measured on imaging predicts early recurrence and death in breast cancer patients with lymph node involvements.

Nagashima T, Sakakibara M, Kadowaki M, Suzuki TH, Yokomizo J, Ohki Y, Miyoshi T, Kazama T, Nakatani Y, Miyazaki M.

Acta Radiol. 2011 Apr 1;52(3):241-6. doi: 10.1258/ar.2010.100334. Epub 2011 Mar 3.

PMID:
21498357
17.

Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.

von Minckwitz G, Kümmel S, Vogel P, Hanusch C, Eidtmann H, Hilfrich J, Gerber B, Huober J, Costa SD, Jackisch C, Loibl S, Mehta K, Kaufmann M; German Breast Group.

J Natl Cancer Inst. 2008 Apr 16;100(8):552-62. doi: 10.1093/jnci/djn089. Epub 2008 Apr 8.

PMID:
18398094
18.

Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound.

Lin CY, Cao LH, Wang JW, Zheng W, Chen Y, Feng ZZ, Li AH, Zhou JH.

BMC Cancer. 2013 Jun 21;13:302. doi: 10.1186/1471-2407-13-302.

20.

Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.

Dose Schwarz J, Bader M, Jenicke L, Hemminger G, Jänicke F, Avril N.

J Nucl Med. 2005 Jul;46(7):1144-50.

Supplemental Content

Support Center